Objective: To determine the long-term safety of flunisolide hydrofluoroalkane (HFA) in adults and adolescents with mild-to-moderate asthma. Design and Setting: A 1-year multicentre, randomised ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback